Aurinia Pharmaceuticals Inc. Quarterly Operating Margin in % from Q4 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q2 2024.
  • Aurinia Pharmaceuticals Inc. Operating Margin for the quarter ending June 30, 2024 was -29.3 %, a 43.7% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Operating Margin for 2023 was -52.2 %, a 37.2% increase from 2022.
  • Aurinia Pharmaceuticals Inc. annual Operating Margin for 2022 was -83.2 %, a 79% increase from 2021.
  • Aurinia Pharmaceuticals Inc. annual Operating Margin for 2021 was -396 %, a 90.5% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -29.3 +22.8 +43.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -39.4 +30.9 +44% Jan 1, 2024 Mar 31, 2024
Q4 2023 -52.2 +30.9 +37.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -56.7 +33.3 +37% Jul 1, 2023 Sep 30, 2023
Q2 2023 -52.1 +127 +70.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -70.3 +183 +72.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -83.2 +313 +79% Oct 1, 2022 Dec 31, 2022
Q3 2022 -90 +126 +58.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -179 -7.54 -4.41% Apr 1, 2022 Jun 30, 2022
Q1 2022 -253 -136 -116% Jan 1, 2022 Mar 31, 2022
Q4 2021 -396 -321 -425% Oct 1, 2021 Dec 31, 2021
Q3 2021 -216 -104 -92.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -171 -43.1 -33.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -117 -0.42 -0.36% Jan 1, 2021 Mar 31, 2021
Q4 2020 -75.6 +27.5 +26.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -112 Jul 1, 2020 Sep 30, 2020
Q2 2020 -128 Apr 1, 2020 Jun 30, 2020
Q1 2020 -117 Jan 1, 2020 Mar 31, 2020
Q4 2019 -103 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.